“…Furthermore, a reduction in Akt protein levels has been observed in the hippocampus and frontal cortex in postmortem brain samples and lymphocytes from patients with schizophrenia compared with healthy control subjects (Emamian et al, 2004). In addition, Disrupted-InSchizophrenia 1 (DISC1) and Neuregulin 1 (NRG1), the genetic variants that have been shown to contribute to the pathogenesis of schizophrenia (Ross et al, 2006), have been shown to affect the Akt/GSK-3 signaling pathway in various experimental models (Mao et al, 2009;Prata et al, 2009;Kéri et al, 2010Kéri et al, , 2011Sei et al, 2010;Lipina et al, 2011), indicating that complex interactions exist among the network of schizophrenia-related proteins (Beaulieu et al, 2009;Karam et al, 2010). Recent evidence has indicated that a decrease in Neuregulin 1-induced Akt phosphorylation is associated with an impaired sensory gating mechanism in first-episode patients with schizophrenia (Kim et al, 2009).…”